[1]沙滨,朱婉华.名老中医朱婉华治疗风湿病特色用药经验浅析[J].现代中医药,2023,(01):056-61.[doi:10.13424/j.cnki.mtcm.2023.01.010]
　SHA Bin?ZHU Wanhua.An Analysis of ZHU Wanhuas Experience in Treating Rheumatology with Characteristic Medication[J].Modern Traditional Chinese Medicine,2023,(01):056-61.[doi:10.13424/j.cnki.mtcm.2023.01.010]
点击复制

名老中医朱婉华治疗风湿病特色用药经验浅析
分享到：

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2023年01期
页码:
056-61
栏目:
学术探讨
出版日期:
2023-01-20

文章信息/Info

Title:
An Analysis of ZHU Wanhuas Experience in Treating Rheumatology with Characteristic Medication
文章编号:
1672-0571(2023)01-0056-06
作者:
沙滨; 朱婉华
南通良春中医医院，江苏 南通 226009
Author(s):
SHA Bin?ZHU Wanhua
Nantong Liangchun Hospital of Traditional Chinese Medicine,Jiangsu Nantong 226009,China
关键词:
朱婉华; 风湿病; 特色用药; 辨病论治
Keywords:
ZHU Wanhua; Rheumatism; Characteristic medicine; Disease differentiation and treatment
分类号:
R255.6??
DOI:
10.13424/j.cnki.mtcm.2023.01.010
文献标志码:
A??
摘要:
风湿病种类繁多，临床表现复杂，中西医治疗方法多种多样，西药治疗疗效确切，却也相对不良反应较多，中医药治疗安全副作用小，却也相对起效缓慢，疗效逊于西药。国医大师朱良春教授曾撰文指出辨证与辨病相结合可提高临床疗效，朱婉华教授传承并发扬他的学术思想，以辨证论治为基础，以辨病（辨症）论治为补充，在其多年临证经验中，发掘并总结出了一批专病专症用药，经临床检验，可确实提高疗效，值得推广使用。
Abstract:
Rheumatology has a wide variety，complex clinical manifestations，and a variety of traditional Chinese and western medicine treatments.Western medicine has a definite therapeutic effect，but it also has relatively more adverse reactions.Traditional Chinese medicine has less safety side effects，but it also has a relatively slow onset of effect，which is inferior to western medicine.Professor ZHU Liangchun，national master of traditional Chinese medicine，once wrote that the combination of syndrome differentiation and disease differentiation can improve the clinical efficacy.Professor ZHU Wanhua inherited and carried forward his academic ideas，based on syndrome differentiation and treatment，supplemented by disease differentiation.In his many years of clinical experience，he discovered and summarized a number of drugs for specific diseases and diseases.After clinical tests，they can really improve the efficacy and are worth promoting.

参考文献/References:

［1］刘红星,赵亚男,陆福.风湿病的中医药治疗进展［J］.中国中医基础医学杂志,2011,17(4):463-464.
［2］景范.风湿病不再是“不死的癌症”［J］.江苏卫生保健,2021(5):24-25.
［3］Smolen Josef S,Landewé Robert B M,Bijlsma Johannes W J,et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs：2019 update［J］.Annals of the rheumatic diseases,2020,79(6).
［4］陈小奇.生物制剂在风湿病的应用［J］.医学新知杂志,2019,29(5):537-540.
［5］Fleischmann Roy.Recent issues in JAK inhibitor safety：perspective for the clinician［J］.Expert review of clinical immunology,2022,18(3).
［6］孟庆良,张子扬,孟婉婷.朱良春教授益肾蠲痹法治疗风湿病经验［J］.中医学报,2017,32(11):2103-2106.
［7］蒋恬,顾冬梅,朱婉华.朱良春教授治疗风湿病学术思想和诊疗技术简介［J］.新中医,2011,43(6):150-151.
［8］朱良春.医学微言［M］.北京:人民卫生出版社,1996:11．
［9］沙滨,朱婉华.从孟河医派的传承谈虫类药在风湿病中的应用［J］.风湿病与关节炎,2020,9(8):64-65,75.
［10］潘峰,朱剑萍,郭建文.朱良春应用痹通汤治疗疑难杂症经验［J］.中医杂志,2013,54(16):1360-1362.
［11］郭锦晨,刘健,孙珍珍,等.基于数据挖掘的中医药治疗风湿病关节炎的处方用药规律分析［J］.中药药理与临床,2020,36(3):258-264.
［12］王纶.明医杂著［M］.南京:江苏科学技术出版社,1985.
［13］李俊圻,王雷.熟地消肾虚之痰饮刍议［J］.亚太传统医药,2017,13(24):40-41.
［14］陈舒茵,梁国成,秦辛.青风藤的化学成分与药理研究现状［J］.亚太传统医药,2022,18(3):207-212.
［15］司敏,孙倩舒,丁洪成,等.穿山龙总皂苷对去卵巢模型大鼠骨质疏松的改善作用［J］.中国药业,2022,31(2):57-61.
［16］邢峰丽,封若雨,孙芳.皂角刺的药理作用研究进展［J］.环球中医药,2017,10(10):1267-1270.
［17］李世昌,彭寿杰,王一博,等.重楼本草考证［J/OL］.中成药:1-9［2022-03-28］.http://kns.cnki.net/kcms/detail/31.1368.R.20220120.0947.006.html.
［18］孙红,王少明,庄捷,等.土茯苓等中药抑制URAT1表达及降尿酸作用筛选研究［J］.中国临床药理学与治疗学,2012,17(4):403-407.
［19］费洪荣,毛幼桦,朱玮,等.粉萆薢降尿酸作用研究［J］.医药导报,2007,26(11):1270-1272.
［20］傅奕,李鑫,朱莹,等.慢性肾功能衰竭用药规律及潜在机制分析［J］.中国实验方剂学杂志,2022,28(6):151-158.
［21］李娟,杨柱,陈杰,等.国医大师刘尚义治疗慢性肾衰用药经验数据挖掘［J］.辽宁中医药大学学报,2018,20(4):114-116.
［22］朱建华,朱婉华.热痹佐用热药的体会［J］.中医杂志,1989,30(2):16-18.
［23］王皓南,黄必胜,詹志来.拳参的化学成分和药理作用最新研究进展［J］.世界科学技术-中医药现代化,2020,22(8):2998-3007.
［24］陈焰.金银花与忍冬藤的药理作用差异简述［J］.中国继续医学教育,2017,9(17):198-199.
［25］朱良春.朱良春医集［M］.长沙:中南大学出版社,2007:302-303.
［26］朱良春.辨证与辨病相结合，提高临床疗效［J］.中医药通报,2011,10(1):1-3.

备注/Memo

备注/Memo:
基金项目：国家重点研发专项“中医药现代化研究”重点专项基金（2019YFC1708501）；江苏省名老中医药专家朱婉华传承工作室（苏中医科教［2019］10号）
更新日期/Last Update: 2023-01-20